Claims for Patent: 8,367,415

Summary for Patent: 8,367,415

Title:	Specific gene polymorphisms in breast cancer diagnosis, prevention and treatment
Abstract:	A method for detecting a predisposition to breast cancer in a subject is provided. The method includes detecting in a biological sample from the subject one or more polymorphisms in the sequence of CD44 gene. The presence of one or more polymorphisms in the sequence of CD44 gene indicates that the subject has a predisposition for developing breast cancer.
Inventor(s):	Zhou; Juhua (Lexington, SC), Nagarkatti; Mitzi (Columbia, SC), Nagarkatti; Prakash (Columbia, SC)
Assignee:	University of South Carolina (Columbia, SC)
Application Number:	12/555,128
Patent Claims:	1. A method for detecting a predisposition to breast cancer in a subject, comprising: obtaining a biological sample from a subject; isolating genomic DNA from the biological sample; amplifying CD44 exon2 region sequences including the CD44 exon2 sequence and boundary sequences between exon2 and upstream intron and between exon2 and downstream intron from the genomic DNA in the presence of a forward primer SEQ ID NO: 1 and a reverse primer SEQ ID NO: 2 to form amplification products; and detecting in the amplification products one or more polymorphisms, wherein the presence of one or more polymorphisms in the sequence of CD44 exon2 gene indicates that the subject has a predisposition for developing breast cancer. 2. The method as in claim 1, wherein the subject is a human. 3. The method as in claim 1, wherein the biological sample comprises blood. 4. The method as in claim 1, wherein the biological sample comprises peripheral blood mononuclear cells. 5. The method as in claim 1, further comprising performing a visualization method of a breast of the subject comprising one or more of MRI, mammography, or ultrasonography to detect breast cancer. 6. The method as in claim 1, wherein the predisposition is an inherited predisposition. 7. The method as in claim 1, wherein the one or more polymorphisms in the sequence of CD44 gene comprises Ex2+14 A>G. 8. The method as in claim 1, further comprising cloning the amplification products to form cloned PCR products. 9. The method as in claim 8, further comprising transforming the cloned PCR products into bacterial competent cells to develop plasmid DNA samples containing the cloned PCR products. 10. The method as in claim 9, further comprising isolating the plasmid DNA samples containing the cloned PCR products. 11. The method as in claim 10, further comprising sequencing the plasmid DNA samples. 12. The method as in claim 11, further comprising analyzing the polymorphisms and the adjacent intron sequences.

Details for Patent 8,367,415

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2028-09-05
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2028-09-05
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2028-09-05